Related references
Note: Only part of the references are listed.Targeting the Vicious Inflammation-Oxidative Stress Cycle for the Management of Heart Failure
Neelam Khaper et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Thyroid Replacement Therapy and Heart Failure
Anthony Martin Gerdes et al.
CIRCULATION (2010)
Proinflammatory cytokines in heart failure: double-edged swords
Mona Hedayat et al.
HEART FAILURE REVIEWS (2010)
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice
Denghong Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Integrated Cytokine and Metabolic Analysis of Pathological Responses to Parasite Exposure in Rodents
Jasmina Saric et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
Matthew R. Janes et al.
NATURE MEDICINE (2010)
Critical Role for IL-6 in Hypertrophy and Fibrosis in Chronic Cardiac Allograft Rejection
J. A. Diaz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity
M. D. Saeemann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure
Borut Jug et al.
HEART AND VESSELS (2009)
Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload
Ying Xia et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2009)
Mammalian Target of Rapamycin Is a Critical Regulator of Cardiac Hypertrophy in Spontaneously Hypertensive Rats
Will Soesanto et al.
HYPERTENSION (2009)
Protein Kinase C-δ and Phosphatidylinositol 3-Kinase/Akt Activate Mammalian Target of Rapamycin to Modulate NF-κB Activation and Intercellular Adhesion Molecule-1 (ICAM-1) Expression in Endothelial Cells
Mohd Minhajuddin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Noninvasive Detection of Fibrosis Applying Contrast-Enhanced Cardiac Magnetic Resonance in Different Forms of Left Ventricular Hypertrophy Relation to Remodeling
Andre Rudolph et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Morris E. Feldman et al.
PLOS BIOLOGY (2009)
Pycnogenol, an extract from French maritime pine, suppresses Toll-like receptor 4-mediated expression of adipose differentiation-related protein in macrophages
Jian-Qiu Gu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction
Leo Timmers et al.
CIRCULATION RESEARCH (2008)
Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells
Frank Schmitz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Thomas Weichhart et al.
IMMUNITY (2008)
Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function
Wei-Hua Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cytokines and myocardial dysfunction: State of the art
Ayman A. El-Menyar
JOURNAL OF CARDIAC FAILURE (2008)
Origin and physiological roles of inflammation
Ruslan Medzhitov
NATURE (2008)
FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression
Jian-Hua Mao et al.
SCIENCE (2008)
Rapamycin prevents thyroid hormone-induced cardiac hypertrophy
James A. Kuzman et al.
ENDOCRINOLOGY (2007)
Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis
Norimichi Koitabashi et al.
HYPERTENSION (2007)
Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure
Ping Zhang et al.
CIRCULATION RESEARCH (2007)
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
Estela Jacinto et al.
CELL (2006)
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase
J. Avruch et al.
ONCOGENE (2006)
Effects of chronic Akt activation on glucose uptake in the heart
T Matsui et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
I Shiojima et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
L-Thyroxine activates Akt signaling in the heart
JA Kuzman et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation
S Fredj et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Does load-induced ventricular hypertrophy progress to systolic heart failure?
K Berenji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Poly(ADP-ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure
CY Xiao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications
P Aukrust et al.
ANNALS OF MEDICINE (2005)
Restraining PI3K: mTOR signalling goes back to the membrane
LS Harrington et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Hypertrophy of the heart - A new therapeutic target?
N Frey et al.
CIRCULATION (2004)
Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB
K Asehnoune et al.
JOURNAL OF IMMUNOLOGY (2004)
Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis
EA Kurt-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy
JR McMullen et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload
JR McMullen et al.
CIRCULATION (2004)
Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts
I Makarenko et al.
CIRCULATION RESEARCH (2004)
Rapamycin attenuates load-induced cardiac hypertrophy in mice
T Shioi et al.
CIRCULATION (2003)
Inflammatory mediators and the failing heart: A translational approach
A Diwan et al.
CURRENT MOLECULAR MEDICINE (2003)
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
K Hara et al.
CELL (2002)
Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart
T Matsui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CTGF expression is induced by TGF-β in cardiac fibroblasts and cardiac myocytes:: a potential role in heart fibrosis
MM Chen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Share Paper
